Guangming TAN
Back
Title
Assistant Professor
Home Department
Medicine and Therapeutics
Email
gtan@cuhk.edu.hk
Office Phone No.
(852) 3505 2195
Office Address
Room 114037, 9/F, Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, Sha Tin
Website
https://www.mect.cuhk.edu.hk/people/guangmingtan.html
ORCID ID
0000-0001-6828-6269
Web of Science
NDL-6441-2025
Research Interests
Specialised Research Area
Biography
Selected Awards
Selected Publications
Research Interests
  • Digital Solution for Cardiovascular Disease
  • Cardiovascular Disease and Risk Factors Prevention
  • Pulmonary Hypertension and Pulmonary Vascular Disease
  • Thromboembolism management
  • Vascular medicine, diagnostic and intervention
  • Exercise Therapy in Cardiovascular Medicine
Specialised Research Area
  • Cardiovascular disease and risk factors awareness in general public and in high-risk patients
  • Cardiovascular disease risk factors control
  • Use of lipid lower therapy in the primary and secondary prevention of cardiovascular mortality
  • Pharmacological management of pulmonary arterial hypertension
  • Pharmacological treatment of congestive heart failure
  • Utilization of mobile health and telemedicine in optimization of cardiovascular care
  • Diagnosis and evaluation of peripheral vascular disease in general and high-risk population
  • Epidemiology and outcome of peripheral vascular disease in Hong Kong
  • Trends of management of peripheral vascular disease in Hong Kong
  • Pharmacological and nonpharmacological treatment of peripheral vascular disease
  • Pharmaco-mechanical treatment of acute & chronic venous and arterial thromboembolism
  • Endovascular intervention for Chronic Thromboembolic Pulmonary Hypertension
  • Advanced endovascular procedures for critical limb ischemia & limb preservation
  • Clinical outcomes of intervention on left main coronary artery
  • Techniques and devices in endovascular and endovenous intervention
  • Transcatheter treatment of malignant pericardial effusion
  • Effects COVID-19 outbreak on medical out-patient visit
Biography

Guangming Tan obtained his medical degree at the Chinse University of Hong Kong. He completed his physician and cardiology specialist training at the Prince of Wales Hospital in Hong Kong. Guangming undertook his oversea fellowship in Vascular Medicine and Intervention at the Massachusetts General Hospital, Harvard Medical School, Boston from year 2017 -2018. He is currently working as a Clinical Assistant Professor at the Chinese University of Hong Kong. Guangming is a cardiologist with qualification of FRCP (Edin), FACC, FESC and RPVI. His research interest is in heart failure, coronary artery disease, cardiovascular risk factors management, peripheral vascular disease, pulmonary vascular disease, digital solution to cardiovascular disease, exercise therapy and endovascular intervention.

Selected Awards
  1. Young Investigator Research Grant, Hong Kong College of Physicians (HKCP) (2023)
  2. Hong Kong Heart Foundation Fellow 2017 – 2018, Hong Kong Society of Transcatheter Endo cardiovascular Therapeutics (HKSTENT) (2017)
  3. Best Case Award, Cardiovascular Interventional Summit (CIS), Hong Kong College of Physicians (HKCP) (2015)
  4. Best Case Award, Cardiovascular Intervention Complication Forum (CICF), Hong Kong College of Cardiology (HKCC) (2014)
  5. Best Case Award, Cardiovascular Interventional Summit (CIS), Hong Kong College of Cardiology (HKCC) (2014)
  6.  Mrs. Reedy Beau Memorial Prize, The Chinese University of Hong Kong (2008)
Selected Publications

 

  1. Yan BPY, Kam KKH, Lai A, Ng CLH, Chan NY, Chan LS, Wong CW, Yam PW, Chi WK, Chan SL, Wong RHL, Wu EB, Chan JYS, Lee APW, Tan GM. Balloon pericardiotomy for malignant pericardial effusion: the PMAP trial. European Heart Journal. 2025:ehaf516. doi:10.1093/eurheartj/ehaf516.
  2. Tan GM. Maternal and fetal outcomes and risk assessment in pregnancies associated with structural heart diseases: a single tertiary center experience. Journal of the American College of Cardiology. 2016;67(13 Suppl).
  3. Chi WK, Tan GM, Yan BP. Prognostic nutritional index as a predictor of prognosis in patients with critical limb ischemia who underwent endovascular revascularization therapy. Journal of the American College of Cardiology. 2019;73(9 Suppl 1):2064. doi:10.1016/S0735-1097(19)32604-4.
  4. Tam MTK, Chan JYS, Chan CP, Wu EB, Lai A, Au ACK, Chi WK, Tan G, Yan BP. Effect of pulsed-field ablation on human coronary arteries: a longitudinal study with intracoronary imaging. JACC: Clinical Electrophysiology. 2025. doi:10.1016/j.jacep.2025.00173.
  5. Li W, Zhang J, Liao J, Zhu M, Wang X, Zhou X, Ma Z, Elhousseini Hilal M, Chua SL, Tan G, Yan BP, Khoo BL. A novel hand-held spinning platform with centrifugal microfluidics for rapid, cost-effective urinary total protein detection at the point of care. Analytical Chemistry. 2025;97(28):15049-15059. doi:10.1021/acs.analchem.5c02549.
  6. Tan GM, Yan BP. Mid-term results of a novel dedicated venous stent for chronic thoracic central vein obstruction. European Journal of Vascular and Endovascular Surgery. 2019;57(3):417-423. doi:10.1016/j.ejvs.2018.10.008.
  7. Tan G, Lai A, Ma WCS, Leung JYW, Yan BP. Evaluation of a self-administered claudication plantarflexion test for screening of peripheral arterial disease. European Journal of Vascular and Endovascular Surgery. 2025. doi:10.1016/j.ejvs.2025.01065.
  8. Tam MTK, Cheng YW, Chan JYS, Chan CP, Au ACK, Fan KWS, Chim TMY, Kwok WY, Fong FK, Lai A, Tan GM, Yan BP. Aveir VR real-world performance and chronic pacing threshold prediction using mapping and fixation electrical data. Europace. 2024;26(3):euae051. doi:10.1093/europace/euae051.
  9. Li W, Wang X, Zhu M, Huang X, Umutoni PH, Chen TH, Lu J, Chen SC, Tan GM, Yan BP, Khoo BL. Multimodal triple-mode probe with colorimetric-fluorescence-SERS for sensitive and quantitative detection of C-reactive protein in clinical diagnostics. Talanta. 2025;293:128100. doi:10.1016/j.talanta.2025.128100.
  10. Wong GLH, Wong VWS, Tan GM, Ip KI, Lai WK, Li YW, Mak MS, Lai PB, Sung JJY, Chan HL. Surveillance programme for hepatocellular carcinoma improves survival. Liver International. 2008;28(1):79-87. doi:10.1111/j.1478-3231.2007.01614.x.
  11. Wong GLH, Wong VWS, Tan GM, Ip KI, Lai WK, Li YW, Mak MS, Lai PB, Sung JJY, Chan HL. Surveillance programme for hepatocellular carcinoma improves survival. Liver International. 2008;28(1):79-87. doi:10.1111/j.1478-3231.2007.01614.x.
  12. Tan GM. A case of Henoch-Schönlein purpura with cardiopulmonary involvement. Rheumatology Reports. 2015;7(1):5854. doi:10.4081/rr.2015.5854
  13. Zhang Y, Jing Z, Liu Z, Lai A, Tan G, Yan BP. Non-HDL-C to HDL-C ratio and cardiovascular events in PAD. Scientific Reports. 2025;15(1):35993. doi:10.1038/s41598-025-35993.
  14. Tan GM, Lai CY, Yan B. A novel non-surgical treatment for iatrogenic radial artery pseudoaneurysm: a case series. Catheterization and Cardiovascular Interventions. 2025;106(4):2410-2413. doi:10.1002/ccd.70081.
  15. Tan GM, Wu E, Lam YY, Yan BP. Warfarin pharmacogenetic testing in clinical practice. Pharmacogenomics. 2010;11(3):439-448. doi:10.2217/pgs.09.
  16. Kam THH, Kam KKH, Wong MKL, Yan BPY, Tan G. Haemodynamic and clinical impacts of switching phosphodiesterase-5 inhibitors to riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) after balloon pulmonary angioplasty (BPA): a prospective cohort study. BMC Pulmonary Medicine. 2026;26:42. doi:10.1186/s12890-025-04069-y
  17. Lee CH, Tan G, Tang SCW, Ng YW, Lee MKY, Chan JWM, Chan TM. Cardiovascular-kidney-metabolic health framework position statement. Hong Kong Medical Journal. 2025.
  18. Tan G, Yip HC, Siu HY, Yao AY, Yan BPY. Evaluation of a brief educational intervention in enhancing venous thromboembolism knowledge among surgical patients and health-care providers: A prospective study. Vascular Health and Risk Management. 2025;21:879-887. doi:10.2147/VHRM.S542572.
  19. Tan G, Kam THH, Lai ECY, Fong EYH, Yeung JYK, Yan BP. Mechanical aspiration for pulmonary embolism. Pulmonary Circulation. 2025;15(4):e70206. doi:10.1002/pul2.70206.
  20. Tan GM, Wu E, Lam YY, Yan BP. Novel platelet ADP P2Y12 inhibitors in ACS. Cardiovascular Therapeutics. 2011;30:210-215. doi:10.1111/j.1755-5922.2010.00227.x.